Faculty Rank: Associate Professor
Medical or Graduate Education:
Indiana University School of Medicine
University of Colorado - Internal Medicine
University of Colorado - Movement Disorders
Botulinum toxin injections
Movement disorders, fragile X-associated
Multiple system atrophy
Progressive supranuclear palsy
Restless legs syndrome (RLS)
Genetics and movement disorders
Fragile X-associated tremor/ataxia syndrome
Clinical trials in Parkinson's disease
Exercise in movement disorders
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Psychometric properties of the Tinnitus Functional Index (TFI): Assessment in a UK research volunteer population. Fackrell K, Hall DA, Barry JG, Hoare DJ Hear. Res. 2015 Sep 27 :. Costly Signaling Increases Trust, Even Across Religious Affiliations. Hall DL, Cohen AB, Meyer KK, Varley AH, Brewer GA Psychol Sci 2015 Sep 26(9):1368-76. Groundwater pesticide levels and the association with Parkinson disease. James KA, Hall DA Int. J. Toxicol. 2015 May-Jun 34(3):266-73. Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England. Martinez C, Wallenhorst C, McFerran D, Hall DA Ear Hear 2015 May-Jun 36(3):e69-75. Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). O'Keefe JA, Robertson-Dick E, Dunn EJ, Li Y, Deng Y, Fiutko AN, Berry-Kravis E, Hall DA Cerebellum 2015 Mar 13 :. Consensus on Hearing Aid Candidature and Fitting for Mild Hearing Loss, With and Without Tinnitus: Delphi Review. Sereda M, Hoare DJ, Nicholson R, Smith S, Hall DA Ear Hear 2015 Jul-Aug 36(4):417-29. Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome. O'Keefe JA, Robertson-Dick EE, Hall DA, Berry-Kravis E Cerebellum 2015 Aug 23 :. Relationship between tinnitus pitch and edge of hearing loss in individuals with a narrow tinnitus bandwidth. Sereda M, Edmondson-Jones M, Hall DA Int J Audiol 2015 Apr 54(4):249-56. Source space estimation of oscillatory power and brain connectivity in tinnitus. Zobay O, Palmer AR, Hall DA, Sereda M, Adjamian P PLoS ONE 2015 10(3):e0120123. Erratum: Emerging topics in FXTAS. Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe JA, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA J Neurodev Disord 2015 7(1):13. Toward a Global Consensus on Outcome Measures for Clinical Trials in Tinnitus: Report From the First International Meeting of the COMiT Initiative, November 14, 2014, Amsterdam, The Netherlands. Hall DA, Haider H, Kikidis D, Mielczarek M, Mazurek B, Szczepek AJ, Cederroth CR Trends Hear 2015 19:. Subtyping Somatic Tinnitus: A Cross-Sectional UK Cohort Study of Demographic, Clinical and Audiological Characteristics. Ward J, Vella C, Hoare DJ, Hall DA PLoS ONE 2015 10(5):e0126254. Neuroanatomical abnormalities in chronic tinnitus in the human brain. Adjamian P, Hall DA, Palmer AR, Allan TW, Langers DR Neurosci Biobehav Rev 2014 Sep 45:119-33. Neuroimaging paradigms for tonotopic mapping (II): the influence of acquisition protocol. Langers DR, Sanchez-Panchuelo RM, Francis ST, Krumbholz K, Hall DA Neuroimage 2014 Oct 15 100:663-75. Neuroimaging paradigms for tonotopic mapping (I): the influence of sound stimulus type. Langers DR, Krumbholz K, Bowtell RW, Hall DA Neuroimage 2014 Oct 15 100:650-62. Fragile X gene expansions are not associated with dementia. Hall DA, Bennett DA, Filley CM, Shah RC, Kluger B, Ouyang B, Berry-Kravis E Neurobiol. Aging 2014 May 2 Pitch coding and pitch processing in the human brain. Plack CJ, Barker D, Hall DA Hear. Res. 2014 Jan 307:53-64. Special issue in Hearing Research: human auditory neuroimaging. Hall DA, Langers DR Hear. Res. 2014 Jan 307:1-3. Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome. O'Keefe JA, Espinoza Orías AA, Khan H, Hall DA, Berry-Kravis E, Wimmer MA Gait Posture 2014 Feb 39(2):827-30. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman RJ, Zhang L Parkinsonism Relat. Disord. 2014 Apr 20(4):456-9. Emerging topics in FXTAS. Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA J Neurodev Disord 2014 6(1):31. New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype. Fraint A, Vittal P, Szewka A, Bernard B, Berry-Kravis E, Hall DA Front Genet 2014 5:365. Gameplay as a source of intrinsic motivation in a randomized controlled trial of auditory training for tinnitus. Hoare DJ, Van Labeke N, McCormack A, Sereda M, Smith S, Al Taher H, Kowalkowski VL, Sharples M, Hall DA PLoS ONE 2014 9(9):e107430. A scientific cognitive-behavioral model of tinnitus: novel conceptualizations of tinnitus distress. McKenna L, Handscomb L, Hoare DJ, Hall DA Front Neurol 2014 5:196. In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions? Hall DA Tremor Other Hyperkinet Mov (N Y) 2014 4:208. Agreement and reliability of tinnitus loudness matching and pitch likeness rating. Hoare DJ, Edmondson-Jones M, Gander PE, Hall DA PLoS ONE 2014 9(12):e114553. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D Cochrane Database Syst Rev 2014 1:CD010151. Tinnitus. Baguley D, McFerran D, Hall D Lancet 2013 Nov 9 382(9904):1600-7. Clinical neurogenetics: fragile x-associated tremor/ataxia syndrome. Hall DA, O'Keefe JA Neurol Clin 2013 Nov 31(4):1073-84. Intranuclear inclusions in a fragile X mosaic male. Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone F. Transl Neurodegener. 2013 2013 May 21 2(1):10. doi: 10.1186/2047-9158-2-10. Recent technological advances in sound-based approaches to tinnitus treatment: a review of efficacy considered against putative physiological mechanisms. Hoare DJ, Adjamian P, Sereda M, Hall DA Noise Health 2013 Mar-Apr 15(63):107-16. Study in Parkinson Disease of Exercise (SPARX): Translating high-intensity exercise from animals to humans. Moore CG, Schenkman M, Kohrt WM, Delitto A, Hall DA, Corcos D. Contemp Clin Trials. 2013 2013 Jun 14 36(1):90-98. doi: 10.1016/j.cct.2013.06.002. [Epub ahead of print] Auditory evoked magnetic fields in individuals with tinnitus. Sereda M, Adjamian P, Edmondson-Jones M, Palmer AR, Hall DA Hear. Res. 2013 Aug 302:50-9. Investigation of cortical and subcortical plasticity following short-term unilateral auditory deprivation in normal hearing adults. Maslin MR, Munro KJ, Lim VK, Purdy SC, Hall DA Neuroreport 2013 Apr 17 24(6):287-91. Representations of pitch and slow modulation in auditory cortex. Barker D, Plack CJ, Hall DA Front Syst Neurosci 2013 7:62. Evaluation of the acoustic coordinated reset (CR®) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial. Hoare DJ, Pierzycki RH, Thomas H, McAlpine D, Hall DA Trials 2013 14:207. A controlled approach to the emotional dilution of the Stroop effect. Fackrell K, Edmondson-Jones M, Hall DA PLoS ONE 2013 8(11):e80141. Mapping pitch representation in neural ensembles with fMRI. Griffiths TD, Hall DA J. Neurosci. 2012 Sep 26 32(39):13343-7. Neuromagnetic indicators of tinnitus and tinnitus masking in patients with and without hearing loss. Adjamian P, Sereda M, Zobay O, Hall DA, Palmer AR J. Assoc. Res. Otolaryngol. 2012 Oct 13(5):715-31. Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Schenkman M, Hall DA, Barón AE, Schwartz RS, Mettler P, Kohrt WM. Phys Ther. 2012 2012 Nov 92(11):1395-410. doi: 10.2522/ptj.20110472. Epub 2012 Jul 19. Concept to reality: integrating technology in the hospital setting. Gwiazdowski A, Hall DE Biomed Instrum Technol 2012 May-Jun 46(3):189-94. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Hall D, Tassone F, Klepitskaya O, Leehey M. Mov Disord. 2012 2012 Feb 27(2):296-300. doi: 10.1002/mds.24021. Epub 2011 Dec 11. How challenges in auditory fMRI led to general advancements for the field. Talavage TM, Hall DA Neuroimage 2012 Aug 15 62(2):641-7. Effects of frequency discrimination training on tinnitus: results from two randomised controlled trials. Hoare DJ, Kowalkowski VL, Hall DA J. Assoc. Res. Otolaryngol. 2012 Aug 13(4):543-59. Reexamining the evidence for a pitch-sensitive region: a human fMRI study using iterated ripple noise. Barker D, Plack CJ, Hall DA Cereb. Cortex 2012 Apr 22(4):745-53. Management of tinnitus in English NHS audiology departments: an evaluation of current practice. Hoare DJ, Gander PE, Collins L, Smith S, Hall DA J Eval Clin Pract 2012 Apr 18(2):326-34. Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment. Hall DA, O'keefe JA. Tremor Other Hyperkinet Mov (N Y). 2012 2012 2. doi:pii: tre-02-56-352-1. Epub 2012 May 11. An evaluation of the content and quality of tinnitus information on websites preferred by General Practitioners. Fackrell K, Hoare DJ, Smith S, McCormack A, Hall DA BMC Med Inform Decis Mak 2012 12:70. Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease. Schenkman M, Ellis T, Christiansen C, Barón AE, Tickle-Degnen L, Hall DA, Wagenaar R Phys Ther 2011 Sep 91(9):1339-54. Re-examining the relationship between audiometric profile and tinnitus pitch. Sereda M, Hall DA, Bosnyak DJ, Edmondson-Jones M, Roberts LE, Adjamian P, Palmer AR Int J Audiol 2011 May 50(5):303-12. Pragmatic communication is impaired in Parkinson disease. Hall D, Ouyang B, Lonnquist E, Newcombe J. Int J Neurosci. 2011 2011 May 121(5):254-6. doi: 10.3109/00207454.2010.550389. Epub 2011 Feb 25. Mapping feature-sensitivity and attentional modulation in human auditory cortex with functional magnetic resonance imaging. Paltoglou AE, Sumner CJ, Hall DA Eur. J. Neurosci. 2011 May 33(9):1733-41. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Hoare DJ, Kowalkowski VL, Kang S, Hall DA Laryngoscope 2011 Jul 121(7):1555-64. Human auditory cortical responses to pitch and to pitch strength. Barker D, Plack CJ, Hall DA Neuroreport 2011 Feb 16 22(3):111-5. Listening to urban soundscapes: Physiological validity of perceptual dimensions. Irwin A, Hall DA, Peters A, Plack CJ Psychophysiology 2011 Feb 48(2):258-68. Clinical guidelines and practice: a commentary on the complexity of tinnitus management. Hoare DJ, Hall DA Eval Health Prof 2011 Dec 34(4):413-20. Executive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype? Berry-Kravis E, Hall DA. Neurology. 2011 2011 Aug 16 77(7):612-3. doi: 10.1212/WNL.0b013e3182299f98. Epub 2011 Jul 20. No abstract available. FMR1 gray-zone alleles: association with Parkinson's disease in women? Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA. Mov Disord. 2011 2011 Aug 15 26(10):1900-6. doi: 10.1002/mds.23755. Epub 2011 May 12. Primary care for tinnitus: practice and opinion among GPs in England. El-Shunnar SK, Hoare DJ, Smith S, Gander PE, Kang S, Fackrell K, Hall DA J Eval Clin Pract 2011 Aug 17(4):684-92. Transmission stages dominate trypanosome within-host dynamics during chronic infections. MacGregor P, Savill NJ, Hall D, Matthews KR Cell Host Microbe 2011 Apr 21 9(4):310-8. Reducing the effects of background noise during auditory functional magnetic resonance imaging of speech processing: qualitative and quantitative comparisons between two image acquisition schemes and noise cancellation. Blackman GA, Hall DA J. Speech Lang. Hear. Res. 2011 Apr 54(2):693-704. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. Hall DA, Láinez MJ, Newman CW, Sanchez TG, Egler M, Tennigkeit F, Koch M, Langguth B BMC Health Serv Res 2011 11:302. Tinnitus referral pathways within the National Health Service in England: a survey of their perceived effectiveness among audiology staff. Gander PE, Hoare DJ, Collins L, Smith S, Hall DA BMC Health Serv Res 2011 11:162. Spatially extended FMRI signal response to stimulus in non-functionally relevant regions of the human brain: preliminary results. Kornak J, Hall DA, Haggard MP Open Neuroimag J 2011 5:24-32. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ. J Clin Psychopharmacol. 2010 2010 Oct 30(5):642-4. doi: 10.1097/JCP.0b013e3181f1d10a. No abstract available. Shoulder pain in Parkinson's disease: a case-control study. Madden MB, Hall DA. Mov Disord. 2010 2010 Jun 15 25(8):1105-6. doi: 10.1002/mds.23048. No abstract available. Parkinsonism and cognitive decline in a fragile X mosaic male. Hall D, Pickler L, Riley K, Tassone F, Hagerman R. Mov Disord. 2010 2010 Jul 30 25(10):1523-4. doi: 10.1002/mds.23150. No abstract available. The efficacy of auditory perceptual training for tinnitus: a systematic review. Hoare DJ, Stacey PC, Hall DA Ann Behav Med 2010 Dec 40(3):313-24. Tremor in 48,XXYY syndrome. Tartaglia N, Borodyanskaya M, Hall DA. Mov Disord. 2009 2009 Oct 15 24(13):2001-7. doi: 10.1002/mds.22700. Erratum in: Mov Disord. 2010 Aug 15;25(11):1764. Borodyanskya, Mariya [corrected to Borodyanskaya, Mariya]. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Hall DA, Howard K, Hagerman R, Leehey MA. Parkinsonism Relat Disord. 2009 2009 Feb 15(2):156-9. doi: 10.1016/j.parkreldis.2008.04.037. Epub 2008 Jun 20. Movement disorders associated with aripiprazole use: a case series. Hall DA, Agarwal P, Griffith A, Segro V, Seeberger LC. Int J Neurosci. 2009 2009 119(12):2274-9. doi: 10.3109/00207450903225553. Persistent neurobehavioral signs and symptoms following West Nile fever. Hall DA, Tyler KL, Frey KL, Kozora E, Arciniegas DB. J Neuropsychiatry Clin Neurosci. 2008 Winter 20(1):122-3 Endurance exercise training to improve economy of movement of people with Parkinson disease: three case reports. Schenkman M, Hall D, Kumar R, Kohrt WM. Phys Ther. 2008 Jan 88(1):63-76 Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A. Neuropsychology. 2008 Jan 22(1):48-60. Adult-onset Alexander disease with progressive ataxia and palatal tremor. Howard KL, Hall DA, Moon M, Agarwal P, Newman E, Brenner M. Mov Disord. 2008 Jan 23(1):118-22. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems Hagerman RJ, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, Rainin E, Hagerman H, Hagerman PJ Clin Interv Aging 2008 3(2):251-62
To watch a brief video of Deborah A. Hall, MD, PhD, click the play button at the lower left corner of the video frame below.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
I started to volunteer when I was in junior high. I volunteered at a radiation therapy center for cancer. And once I started to get involved in that, I understood that I could bring together my love of science with the ability to help people. And now here at Rush, I’m involved in gene therapy studies for Parkinson’s disease. We believed for a long time it would be medications that would be the clue to improving patients’ quality of life. But now we have these very exciting therapies that we’re testing in the clinic. And we’re very hopeful that these will be helpful in the long run for patients.
You occasionally have a patient that comes in and says, “Doc, I’m better.” And that is probably the most rewarding thing that we can hear when we’re in the clinic.
Patient feedback information is available for physicians employed by Rush University Medical Center who have received
30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the
section of the Rush University Medical Center website.